ATRA vs REG · rev $128.9M vs P/E 34, $12.93B cap
Atara Biotherapeutics Inc (ATRA) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
REG does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ATRA and REG stock pages for the full models.
Not investment advice.